DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report to their offering.
The Global Psoriasis Treatment Market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.
The psoriasis treatment market is rapidly growing due to factors such as growing prevalence in some countries, significant unmet needs, promising pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of study, global psoriasis treatment market is segmented on the basis of drug class such as TNF Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its long-term safety with lower risk of infection and malignancy. Psoriasis treatment market is categorized on the basis of route of administration such as topical, oral and parenteral therapeutic drugs.
Currently, topical therapeutic drugs hold largest market share due to its safety, more effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would show significant growth during forecast period because newly approved biologics are generally preferred in moderate to severe psoriasis.
- AbbVie Inc.
- Amgen Inc.
- Boehringer Ingelheim
- Eli Lilly and Company
- Johnson & Johnson
- LEO Pharma A/S
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Stiefel Laboratories Inc.
- Sun Pharmaceutical Industries
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Psoriasis Treatment Market Analysis
Chapter 4 Global Psoriasis Treatment Market, by Drug Class
Chapter 5 Global Psoriasis Treatment Market, by Route of Administration
Chapter 6 Global Psoriasis Treatment Market, by Geography
Chapter 7 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/wnpcpw/global_psoriasis